序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
181 히드라지드 및 피라노피라졸의 고체상 합성용 광분해성 링커 KR1020167009377 2014-09-11 KR1020160062035A 2016-06-01 닐센,토마스이.; 큐보르트러프,카트린
본발명의광분해성히드라진링커는 UV 조사시히드라지드유도체를방출할수 있는,-니트로-베라트릴그룹에기초한다. 상기링커는 SPPS에서가장일반적으로사용된보호기및 화학적방법에완전히직교되는신규고체상펩티드합성 (SPPS) 전략을허용하고, 합성전략은펩티드조성물과우수한호환성을나타내고, 특히모두 20개의천연적으로발생한α-아미노산잔기 (심지어측쇄보호된형태)는펩티드히드라지드의 C-말단에수용된다. 또한, 링커유닛은피라노피라졸과같은, 생물학적관심대상인헤테로시클릭화합물의조합라이브러리를합성하는데적용될수 있다.
182 혐기 경화성 조성물용 경화 촉진제 KR1020107027382 2009-05-05 KR101572706B1 2015-11-27 메사나,앤드류; 자코뱅,앤서니,에프.; 나코스,스티븐,토마스; 글레이저,데이빗,엠.
본발명은하기화학식 I로표시되는화합물의군으로부터선택된화합물(들), 혐기경화촉진제로서의상기화합물의용도, 및상기화합물을포함하는조성물을제공한다: [화학식 I]상기식에서, X, Y 및 R은본원에정의된바와같다.
183 아조디카르복실산 비스(2-알콕시에틸)에스테르 화합물, 그 제조 중간체 KR1020097013144 2008-01-30 KR101025202B1 2011-03-31 하기야카즈타케; 스기무라타카시
본 발명은 인 화합물과 병용하여 탈수 축합 반응을 행하는 미츠노부 반응, 산화제 및 여러가지 합성 원료로서 유용한 공업적으로 안전하고, 또한 유용한 아조디카르복실산 비스(2-알콕시에틸)에스테르 화합물, 그 제조 중간체와, 이들의 제조 방법을 제공하는 것에 있다. 일반식(1); (식 중 A는 탄소수 1~10의 알킬기를 나타냄.)로 나타내어지는 아조디카르복실산 비스(2-알콕시에틸)에스테르 화합물. 아조디카르복실산 비스(2-알콕시에틸)에스테르 화합물
184 혐기 경화성 조성물용 경화 촉진제 KR1020107027382 2009-05-05 KR1020110021850A 2011-03-04 메사나,앤드류; 자코뱅,앤서니,에프.; 나코스,스티븐,토마스; 글레이저,데이빗,엠.
본 발명은 하기 화학식 I로 표시되는 화합물의 군으로부터 선택된 화합물(들), 혐기 경화 촉진제로서의 상기 화합물의 용도, 및 상기 화합물을 포함하는 조성물을 제공한다:
[화학식 I]

상기 식에서, X, Y 및 R 1 은 본원에 정의된 바와 같다.
185 혐기 경화성 조성물용 경화 촉진제 KR1020107027381 2009-05-05 KR1020110021849A 2011-03-04 자코뱅,앤서니,에프.; 메사나,앤드류; 글레이저,데이빗,엠.; 나코스,스티븐,토마스
본 발명은 이소시아네이트 작용성 물질(들)과 하기 화학식 I로 표시되는 화합물의 군으로부터 선택된 화합물(들)의 반응 생성물, 상기 화합물을 혐기 경화 촉진제로서 사용하는 용도, 및 상기 화합물을 포함하는 조성물을 제공한다:
[화학식 I]

상기 식에서, X, Y 및 R 1 은 앞에서 정의한 바와 같다.
186 아조디카르복실산 비스(2-알콕시에틸)에스테르 화합물, 그 제조 중간체 KR1020097013144 2008-01-30 KR1020090088420A 2009-08-19 하기야카즈타케; 스기무라타카시
a bis(2-alkoxyethyl) azodicarboxylate ester compound which can be used in combination with a phosphorus compound in a Mitsunobu reaction for achieving a dehydration/condensation reaction, is useful as an oxidizing agent or a raw material for the synthesis of various compounds, and is safe and useful in an industrial viewpoint; an intermediate for the production of the compound; and a method for producing the compound or the intermediate. Specifically disclosed is a bis(2-alkoxyethyl) azodicarboxylate ester compound represented by the general formula (1). (1) wherein A represents an alkyl group having 1 to 10 carbon atoms. ® KIPO & WIPO 2009
187 살충제 페닐히드라진 유도체 KR1019940701712 1992-11-17 KR1019940703335A 1994-10-24 마크에이치엘데키서; 파울토마스맥도날드
188 트리아실 히드라지드, 이것을 함유하는 조성물 및 이들의 제조 방법 KR1019900006993 1990-05-16 KR1019900018016A 1990-12-20 요셉드라베크
내용 없음
189 N-FLUOROALKYL COMPOUND PRODUCTION METHOD PCT/JP2023047354 2023-12-28 WO2024143558A1 2024-07-04 SHIRAI ATSUSHI; KUROKI YOSHICHIKA; KISHIKAWA YOSUKE; MANABE TOMOYUKI
Provided is a production method comprising a step A for reacting a compound represented by formula (2) [where R1, R2, and R3 are identical or different, R1 represents –COR, R2 and R3 represent a hydrogen atom or –COR, and R4 represents a C1-12 alkyl group or a C6-12 aryl group] with a fluorinating agent containing HF, an amine, and IF5 at not higher than 80°C from the start of the reaction to the end of the reaction. With this method, it is possible to synthesize a compound (N-fluoroalkylated hydrazine derivative) represented by formula (1) [where R1, R2, and R3 are the same as above, and each R is identical or different and represents a C6-12 aryloxy group or a C1-12 alkoxy group that may be substituted with one or more substituents].
190 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, AND ACID DIFFUSION CONTROL AGENT PCT/JP2023038552 2023-10-25 WO2024095868A1 2024-05-10 MATSUSHITA TETSUYA; INARI TAKATOSHI
The present invention provides a resist composition which generates an acid by being exposed to light, and the solubility of which in a developer solution is changed by the action of an acid. This resist composition contains: a resin component (A1), the solubility of which in a developer solution is changed by the action of an acid; and a compound (D0) which is represented by general formula (d0). In the formula, Rd01 represents a monovalent organic group; Rd02 represents a monovalent organic group or a hydrogen atom; and Ld01 represents a single bond or a divalent linking group.
191 CARBAZATE-FUNCTIONAL COMPOUND PCT/US2022080958 2022-12-06 WO2023107909A1 2023-06-15 MAYO MICHAEL ALLEN; XIAO JING; DOMHOFF ALLISON BROOKS; WEIS JONATHAN GARRETT; ZHOU HONGYING; ATMURI ANAND KUMAR
A carbazate-functional compound includes a plurality of groups having the following structure: [formula (I)] where X forms at least a portion of: a urethane linkage, an ester linkage, or an ether linkage. At least one R1 from the plurality of groups is free of a hydroxyl-functional group.
192 METHOD FOR PERFORMING MITSUNOBU REACTION BETWEEN ALCOHOLIC HYDROXYL GROUP DONOR AND ACTIVE HYDROGEN DONOR PCT/CN2020127698 2020-11-10 WO2022088244A1 2022-05-05 YE SHOUCHEN; SONG XIAOLONG; XU SHUANG; ZHAO LILIANG
A method for performing Mitsunobu reaction between an alcoholic hydroxyl group donor and an active hydrogen donor, comprising the following steps: reacting the alcoholic hydroxyl group donor and the active hydrogen donor with a trihydrocarbylphosphine reagent and an azodicarboxylate reagent in the presence of an organic solvent, wherein the organic solvent is a linear or branched alkane containing 8 to 16 carbon atoms.
193 글루탐산 유도체 및 이를 포함하는 조성물 PCT/KR2018/012992 2018-10-30 WO2019088642A1 2019-05-09 안진희; 김민희; 배은정; 파기레수바나 하우스-하바우; 이다혜; 파기레하우샤바우 시바지; 이돈행; 이은혜; 맹진희; 안수경; 김윤희

본 발명은 우수한 항산화 효과를 발휘하는 신규한 글루탐산 유도체 또는 이를 포함하는 항산화 조성물에 관한 것으로서, 본 발명의 조성물을 사용함으로써, 항산화용 화장료 조성물, 항산화용 기능성 식품 조성물, 멜라닌 색소 과다침착 질환의 예방 또는 치료용 약제학적 조성물, 또는 피부 미백용 화장료 조성물을 제공할 수 있다.

194 一种可见光催化的饱和氢键直接化方法 PCT/CN2017/107760 2017-10-26 WO2018133473A1 2018-07-26 左智伟; 胡安华

发明提供了一种有机化合物中饱和氢键的直接化方法,其特征在于,包括:在可见光照射的条件下,使有机化合物与氧化试剂在铈复合物的存在下进行反应,使有机化合物的饱和碳氢键氧化得到氧化产物。本发明反应仅需在室温下进行,催化效率高,仅依靠可见光来提供活化反应所需的能量,是一种更加温和、绿色的活化模式;同时所用的催化剂成本低廉,所用氧化试剂性质更加稳定,在工业上利用成本低,催化体系实用性强;同时能避免重过渡金属,过氧化物等对环境的污染。

195 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI PCT/EP2014/062905 2014-06-18 WO2014202703A1 2014-12-24 WINTER, Christian; RHEINHEIMER, Joachim; WOLF, Antje; TERTERYAN, Violeta; POONOTH, Manojkumar; WIEBE, Christine; KREMZOW-GRAW, Doris; RÖHL, Franz; ROHRER, Sebastian Georgios; WIEJA, Andy; ROSENBAUM, Claudia; GRAMMENOS, Wassilios

The present invention relates to novel strobilurine type compounds I, processes for preparing these compounds, a use of compounds of the formula I and/or their agriculturally useful salts for controlling phytopathogenic fungi, to compositions comprising at least one such compound, to plant health applications, and to seeds coated with at least one such compound.

196 CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS PCT/US2009/042793 2009-05-05 WO2009137444A3 2009-11-12 MESSANA, Andrew; JACOBINE, Anthony, F.; NAKOS, Steven, Thomas; GLASER, David, M.

The present invention provides compound(s) selected from the group of compounds represented by structural Formula (I): wherein X, Y and R1 are described herein, use of such compounds as anaerobic cure accelerators, and compositions including such compounds.

197 VERFAHREN ZUR HERSTELLUNG VON 8-HYDRAZINO-8-ARYL-OCTANOYLDERIVATEN UND DEREN VERWENDUNG PCT/EP2008/008597 2008-10-10 WO2009049837A1 2009-04-23 MEIER, Viktor; STOLZ, Florian; WEDEL, Tobias; REUTER, Karl

Die Erfindung betrifft ein Verfahren zur Herstellung von 8-Aryl-Octanoylderivaten, insbesondere chiralen 8-Hydrazino-8-Aryl-Octanoylamiden, sowie neue Zwischenprodukte, die in dem Verfahren zur Herstellung der genannten Octanoylderivate eingesetzt werden und deren Verwendung.

198 HCV NS-3 SERINE PROTEASE INHIBITORS PCT/SE2005000097 2005-01-28 WO2005073195A3 2005-09-29 ROSENQUIST AASA; THORSTENSSON FREDRIK; JOHANSSON PER-OLA; KVARNSTROEM INGEMAR; SAMUELSSON BERTIL; WALLBERG HANS
Peptidomimetic compounds are described which inhibit the NS3 protease of the hepatitis C virus (HCV). The compounds have the formula where the variable definitions are as provided in the specification. The compounds comprise a carbocyclic P2 unit in conjunction with a novel linkage to those portions of the inhibitor more distal to the nominal cleavage site of the native substrate, which linkage reverses the orientation of peptidic bonds on the distal side relative to those proximal to the cleavage site.
199 METHOD FOR STEREOSELECTIVELY PRODUCING HYDRAZINO CYCLOALKENES AND DIAMINO CYCLOALKANES PCT/EP0112324 2001-10-25 WO0236548A3 2002-09-19 KAUFMANN DIETER E; NANDAKUMAR MECHERIL VALSAN; STORSBERG JOERG
The invention relates to a novel method for carrying out the stereoselective, palladium-catalyzed production of hydrazino cycloalkenes of general formula (Ia) and of diamino bicycloalkanes of general formula (IV), in which A, R<1>, R<2>, R<3> and R<4> have the meanings cited in the description. The invention also relates to compounds that can be obtained according to the method.
200 PROCESS FOR THE PREPARATION OF INSECTICIDAL PHEYNYLHYDRAZINE DERIVATIVES PCT/US2000/028593 2000-10-16 WO01032599A1 2001-05-10
Disclosed herein is an improvement in a method for making compounds having the structural formulae (I) or (II) wherein: X is a) phenyl; lower phenylalkoxy, phenoxy; or benzyl; or b) one subtituent from group a) and one or more substituents selected from C1-C4 alkoxy; hydroxyl; halogen; lower alkyl; and lower alkylthio; or c) along with the phenyl to which it is attached, forms a multiple fused ring heterocycle such as dibenzofuranyl; Y is H, C1-C4 alkanoyl, C1-C4 haloalkanoyl, dialkoxyphosphoryl, alkylaminocarbonyl, haloalkylsulfonyl, or C1-C4 alkoxy carbonyl; and R is H, C1-C6 alkyl, C1-C6 alkoxy, C3-C6 cycloalkoxy, haloalkyl, alkoxyalkyl, arylalkoxy, alkenyl, alkylthio, alkoxycarbonyl, alkylamino, heteroaryl, arylalkyl, haloalkoxy, aryloxy, or C3-C6 cycloalkyl; and Z is O or S, wherein the improvement comprises the steps of: A) selecting as a starting material a compound of structural formula (III); B) dissolving compound III in an organic solvent selected from the group consisting of methyl t-butyl ether, ethylene glycol dimethyl ether, 2-methoxyethyl ether, acetonitrile, and acetic acid, and C) nitrating with nitric acid to form a compound of structural formula (IV).
QQ群二维码
意见反馈